NCT04869865

Brief Summary

This pilot study will evaluate the effects of a Springtime Home Cleanse on skin, gut, metabolic, and mental health. The study will also assess changes in overall quality of life. The results will be used to design a larger cleanse-based study in the future.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
18

participants targeted

Target at below P25 for not_applicable healthy

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 29, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

April 29, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 3, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 3, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 3, 2022

Completed
Last Updated

May 3, 2021

Status Verified

April 1, 2021

Enrollment Period

11 months

First QC Date

April 29, 2021

Last Update Submit

April 29, 2021

Conditions

Keywords

mental healthskin healthgut health

Outcome Measures

Primary Outcomes (2)

  • Microbiota diversity

    Evaluation of gut microbiome diversity

    3 weeks

  • Microbiome intestinal markers

    Zonulin, calprotectin, antibodies against LPS

    3 weeks

Secondary Outcomes (16)

  • Serum hemoglobin A1c (HbA1c) levels

    3 weeks

  • Serum high-sensitivity C-reactive protein (hsCRP) level

    3 weeks

  • Serum triglyceride (TG) level

    3 weeks

  • Serum low density lipoprotein (LDL) level

    3 weeks

  • Serum high density lipoprotein (HDL) level

    3 weeks

  • +11 more secondary outcomes

Study Arms (1)

Intervention

EXPERIMENTAL

Detoxification cleanse

Dietary Supplement: 9-day detoxification cleanse and 1 week of pre-cleanse transition

Interventions

Subjects will participate in the full 9-day Springtime Home Cleanse, including the week prior to a pre-cleanse transition period. The cleanse includes a transition week, 9 days of a monodiet, internal oleation with ghee, external oleation, herbs, purgation, and an enema. During this time, subjects will also attend daily online meetings on Facebook Live throughout the cleanse and on AyurPrana's AyurLearn online portal to participate in guided mediation and yoga. Subjects will also use these platforms to access daily cleanse instructions and journaling topics.

Intervention

Eligibility Criteria

Age18 Years - 69 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Males and females (ages 18-69)
  • Individuals must be able to read and comprehend study procedures and consent forms.
  • Individuals who have baseline metabolic, gut or stress dysfunction
  • Individuals must be able to minimize activity during the home cleanse for full participation and compliance.
  • Individuals must be willing to reduce caffeine, sugar, alcohol, dairy and carbohydrate rich foods throughout the study.
  • Individuals must be willing to have flash photo facial images taken with imaging systems.

You may not qualify if:

  • Individuals with a known allergy to lime or lime juice, ginger or ginger pickle, turbinado sugar, rock salt, curcumin, coriander, fennel, cardamom, cinnamon, trikatu, yellow mung dal, kitchari spice, triphala, dashamula and guduchi powder, castor oil and chyavanprash.
  • Individuals who are lactose intolerant, or with a known allergy to ghee.
  • Individuals who are in the process of being vaccinated.
  • Individual who have a history of gastrointestinal inflammatory diseases or a history or diagnosis of immunologic or infectious disease (e.g. hepatitis, tuberculosis, HIV or AIDS, lupus, rheumatoid arthritis) or other similar systemic diseases in the opinion of the investigator.
  • Individuals who are recovering from a serious illness (requiring hospitalization), infection (requiring hospitalization), or surgery within one month of starting the study or unwilling to wait one month after their illness, infection, or surgery prior to starting the study.
  • Individuals who are recovering from a non-serious illness or infection who are recovered and unwilling to wait 2 weeks from their illness or infection.
  • Individuals who are in a concurrent intervention based clinical research study at this site or any other facility in the past two weeks.
  • Has a condition or is on a medication the investigator and/or designee believes could jeopardize the safety of the subject, interfere with the evaluation, or confound the interpretation of the study results.
  • Individuals who have had exposure to systemic antibiotics within the month prior or unwilling to wash out for a month.
  • Women who are pregnant or breastfeeding.
  • Individuals who are cognitively impaired.
  • Prisoners

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Integrative Skin Science and Research

Sacramento, California, 96815, United States

Location

MeSH Terms

Conditions

Psychological Well-Being

Condition Hierarchy (Ancestors)

Personal SatisfactionBehavior

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: All subjects will be given the intervention
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 29, 2021

First Posted

May 3, 2021

Study Start

April 29, 2021

Primary Completion

April 3, 2022

Study Completion

April 3, 2022

Last Updated

May 3, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations